hrs9531
Recombinant proteinexperimental
Clinical trial activity
26 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
11
Phase 2
15
Phase 3
7
Phase 4
0
Earliest trial started Dec 5, 2021 (NCT05152277)
Timeline
Indications
Mechanism of action
GLP1R agonist
GIPR agonist
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07285902 | Phase 3 | Dec 31, 2025 | Jiangsu ShengDiYa Medicine Co., Ltd. |
| NCT07060456 | Phase 3 | Jul 25, 2025 | Jiangsu ShengDiYa Medicine Co., Ltd. |
| NCT06974851 | Phase 3 | Jul 25, 2025 | Jiangsu ShengDiYa Medicine Co., Ltd. |
| NCT06994650 | Phase 3 | Jun 30, 2025 | Jiangsu ShengDiYa Medicine Co., Ltd. |
| NCT06855147 | Phase 1 | Apr 21, 2025 | Jiangsu ShengDiYa Medicine Co., Ltd. |
| NCT06841445 | Phase 2 | Apr 7, 2025 | Jiangsu ShengDiYa Medicine Co., Ltd. |
| NCT06792955 | Phase 1 | Feb 11, 2025 | Jiangsu ShengDiYa Medicine Co., Ltd. |
| NCT06762600 | Phase 1 | Jan 16, 2025 | Jiangsu ShengDiYa Medicine Co., Ltd. |
| NCT06723691 | Phase 1 | Dec 31, 2024 | Jiangsu ShengDiYa Medicine Co., Ltd. |
| NCT06649344 | Phase 3 | Nov 30, 2024 | Jiangsu ShengDiYa Medicine Co., Ltd. |
| NCT06650007 | Phase 3 | Oct 31, 2024 | Jiangsu ShengDiYa Medicine Co., Ltd. |
| NCT06654960 | Phase 1 | Oct 23, 2024 | Jiangsu ShengDiYa Medicine Co., Ltd. |
| NCT06595797 | Phase 2 | Sep 30, 2024 | Jiangsu ShengDiYa Medicine Co., Ltd. |
| NCT06565871 | Phase 2 | Aug 31, 2024 | Jiangsu ShengDiYa Medicine Co., Ltd. |
| NCT06506175 | Phase 1 | Aug 5, 2024 | Jiangsu ShengDiYa Medicine Co., Ltd. |
| NCT06435676 | Phase 1 | Jun 4, 2024 | Jiangsu ShengDiYa Medicine Co., Ltd. |
| NCT06396429 | Phase 3 | May 13, 2024 | Jiangsu ShengDiYa Medicine Co., Ltd. |
| NCT06391710 | Phase 2 | May 6, 2024 | Jiangsu ShengDiYa Medicine Co., Ltd. |
| NCT06246175 | Phase 1 | Feb 28, 2024 | Jiangsu ShengDiYa Medicine Co., Ltd. |
| NCT06287437 | Phase 2 | Jan 1, 2024 | Fudan University |
Showing 20 of 26 trials
Page 1 / 2
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Jiangsu ShengDiYa Medicine Co., Ltd. | Government | 25 | 25 | 3 | 2021 |
| Fudan University | Academic/Hospital | 1 | 1 | 1 | 2024 |
2 organizations
Page 1 / 1